Investor Alert

The Wall Street Journal Archives | Email alerts

May 22, 2022, 5:41 p.m. EDT

Abbott CEO apologizes for baby formula shortage, promises production ramp-up

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Abbott Laboratories (ABT)

or Cancel Already have a watchlist? Log In

Ginger Adams Otis

Abbott Laboratories Chief Executive Robert Ford apologized Saturday for his company’s role in the  nationwide shortage of baby formula  and promised production will ramp up again in June. 

“We’re sorry to every family we’ve let down,” Ford wrote in a  Washington Post op-ed

Ford explained what led to his company’s voluntary recall of baby formula and detailed the company’s plan to avoid a similar shortage in the future. 

“We are making significant investments to ensure this never happens again,” he wrote. 

In February, Abbott Laboratories /zigman2/quotes/203724446/composite ABT +0.71%   voluntarily recalled  some of its Similac, Alimentum and EleCare formulas manufactured in its Sturgis, Mich., plant after Food and Drug Administration officials found a potentially deadly bacteria there.  That decision exacerbated an existing baby formula shortage created by  supply-chain issues  during the COVID-19 pandemic, Ford acknowledged.

“We take great pride in manufacturing nutrition and formula to feed America’s infants, including our most vulnerable,” Ford said.

An expanded version of this report appears on WSJ.com.

Also popular on WSJ.com:

Old Navy made clothing sizes for everyone. It backfired.

The market is melting down and people are feeling it. ‘My stomach is churning all day.’

$ 102.87
+0.73 +0.71%
Volume: 4.91M
May 26, 2023 4:00p
P/E Ratio
Dividend Yield
Market Cap
$178.89 billion
Rev. per Employee

Get news alerts on Abbott Laboratories — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.